Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

Saved in:
Bibliographic Details
Main Authors: Ottmann, Oliver G. (Author) , Krämer, Alwin (Author) , Bochtler, Tilmann (Author)
Format: Article (Journal)
Language:English
Published: 2019
In: British journal of haematology
Year: 2019, Volume: 184, Issue: 6, Pages: 1018-1021
ISSN:1365-2141
DOI:10.1111/bjh.15204
Online Access:Verlag, Volltext: https://doi.org/10.1111/bjh.15204
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15204
Get full text
Author Notes:Oliver G. Ottmann, Carsten Müller‐Tidow, Alwin Krämer, Richard F. Schlenk, Michael Lübbert, Gesine Bug, Utz Krug, Tilmann Bochtler, Florian Voss, Tillmann Taube, Dan Liu, Pilar Garin‐Chesa, Hartmut Döhner
Description
Item Description:First published: 08 June 2018
Gesehen am 03.06.2019
Physical Description:Online Resource
ISSN:1365-2141
DOI:10.1111/bjh.15204